

Dunhill Ventures Presents: Drinks & Canapés Reception featuring Mitochon Pharmaceuticals
Dunhill Ventures Presents a Drinks & Canapés Reception featuring Mitochon Pharma Advancing Breakthrough Treatments for Neurodegenerative Diseases
We are delighted to invite you to an exclusive Family Offices and Private Investors Brunch in London, where we spotlight a pioneering biotech company making significant strides in the fight against neurodegenerative diseases—Mitochon Pharma.
📍 London
📅 Wednesday, 18th June 2025
🕘 6:30PM - 9:30PM
About Mitochon Pharma Mitochon Pharma is a clinical-stage biopharmaceutical company revolutionizing how we treat conditions such as ALS, Huntington’s, Parkinson’s, MS, and Traumatic Brain Injury. Their focus? Oral, once-daily compounds that enhance mitochondrial function and reduce oxidative stress—a core driver of neurodegeneration.